<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03393403</url>
  </required_header>
  <id_info>
    <org_study_id>KMUHIRB-F(II)-20170001</org_study_id>
    <nct_id>NCT03393403</nct_id>
  </id_info>
  <brief_title>Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer Surgery</brief_title>
  <official_title>Comparison of the Effect of Intravenous Continuous Dexmedetomidine Infusion and Dexmedetomidine as a Local Anesthetic Adjuvant in Subcostal Transverse Abdominis Plane Block in Patients Undergoing Gastric Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using random case assignment to investigate the analgesic and sedative effect of intravenous
      dexmedetomidine and dexmedetomidine as a local anesthetic adjuvant in ultrasound-guided
      subcostal TAP block in gastric cancer patient undergoing gastrectomy or partial gastrectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The process of the experiment (brief describe) The participant patients will be randomly
      allocated into three groups: the intravenous dexmedetomidine group (Dex_iv group),
      dexmedetomidine adding to local anesthetic as an adjuvant for subcostal TAP block (Dex_adj
      group), and Control group. All patients receive gastrectomy or partial gastrectomy in general
      anesthesia as standard. Thirty minutes before the end of surgery, the patients in Dex_iv
      group receive 0.5mcg/kg dexmedetomidine infusion for 30 minutes, while the patients in
      Dex_adj group and control group receive 0.125ml/kg 0.9% normal saline IV infusion for 30
      minutes. All patients have ultrasound-guided TAP block single injection after the end of
      surgery and before the tracheal tube extubation. The block agents in Dex_adj group is 40 ml
      of 0.375% ropivacaine with 0.5mcg/kg dexmedetomidine, while in Dex_iv group and control group
      are only 40ml of 0.375% ropivacaine. The IV PCA pump will be set up before patients awaken in
      the post-anesthesia care unit. All patients are assessed for the signs of emergence agitation
      with Riker sedation-agitation scale in the post-anesthesia care unit. The numerical rating
      scale (NRS) for pain intensity assessment, the opioid consumption via IV PCA pump, and the
      patients satisfaction will be documented for postoperative 3 days for the impact evaluation
      of dexmedetomidine in postoperative analgesia in patients undergoing gastric cancer surgery
      with subcostal TAP block.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 23, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic effect - pain intensity</measure>
    <time_frame>postoperative 3 days</time_frame>
    <description>postoperative acute pain intensity (numerical rating scale, NRS, 0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sedative effect</measure>
    <time_frame>postoperative 2 hours</time_frame>
    <description>emergence agitation in post-anesthesia care unit (Riker sedation-agitation scale, 1-7)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesic effect - opioid consumption</measure>
    <time_frame>postoperative 3 days</time_frame>
    <description>Fentanyl consumption(mcg) via patient-control analgesia (PCA) pump</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine_iv group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 0.5mcg/kg (diluted in normal saline) intravenously infusion for 30min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine_adj group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 0.5mcg/kg (adding to local anesthetic) perineural single bolus for subcostal TAP block 0.9% sodium chloride 0.125ml/kg intravenously infusion for 30min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.9% sodium chloride 0.125ml/kg intravenously infusion for 30min No dexmedetomidine use</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>0.5mcg/kg intravenous(IV)continuous infusion for 30 minutes, or 0.5mcg/kg adding to local anesthetic for subcostal TAP block</description>
    <arm_group_label>Dexmedetomidine_iv group</arm_group_label>
    <arm_group_label>Dexmedetomidine_adj group</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% Sodium-chloride</intervention_name>
    <description>0.125ml/kg intravenously infusion in Dexmedetomidine_adj group and control group</description>
    <arm_group_label>Dexmedetomidine_adj group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  gastric cancer patients undergoing gastrectomy or partial gastrectomy, who receive
             ultrasound-guided subcostal TAP block and PCA for postoperative analgesia

        Exclusion Criteria:

          -  surgery involved other visceral organ (eg. combined splenectomy or partial
             hepatectomy), patients with histories of adverse drug reaction to dexmedetomidine,
             bradycardia (baseline heart rate &lt;60 beats/min), any type of atrioventricular block in
             electrocardiogram (EKG), heart failure, significant renal or hepatic impairment,
             severe bronchopulmonary disease, any coagulant disorder, and pregnant or
             breast-feeding woman.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miao-Pei Su, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miao-Pei Su, M.D.</last_name>
    <phone>0088673121101</phone>
    <phone_ext>7033</phone_ext>
    <email>cavia0803@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Medical University Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miao-Pei Su, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2017</study_first_submitted>
  <study_first_submitted_qc>January 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2018</study_first_posted>
  <last_update_submitted>January 10, 2018</last_update_submitted>
  <last_update_submitted_qc>January 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaohsiung Medical University Chung-Ho Memorial Hospital</investigator_affiliation>
    <investigator_full_name>KMUHIRB-F(II)-20170001</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Subcostal transversus abdominis plane block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

